US OptionsDetailed Quotes
VYGR241220C10000
- 0.00
- 0.000.00%
15min DelayClose Dec 13 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover0.00%IV59.49%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma125.40Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Voyager Therapeutics Stock Discussion
Sign in to post a comment
$Voyager Therapeutics (VYGR.US)$
Very oversold, less than 1% profitable positions, undervalued by all except p/e which is still under market avg.
Very oversold, less than 1% profitable positions, undervalued by all except p/e which is still under market avg.
4
$Voyager Therapeutics (VYGR.US)$ I got in on this around April of this year for around $6.30-6.40 and have been holding it just waiting for it to completely crash. I'm not sure exactly what caused the uptick today but I do know I'm extremely tempted to sell it all off and take the smaller profits (actually I'm definitely going to sell some for that), but I'm not sure, I think this company still has potential long-term, I was just blown away by how stagnant it had been for months. Anyone else have...
4
4
$Voyager Therapeutics (VYGR.US)$
This was over $10 recently, and earnings were great, except Wall St was scared of recession at the time. I'm guessing once they are satisfied, this will go back up
This was over $10 recently, and earnings were great, except Wall St was scared of recession at the time. I'm guessing once they are satisfied, this will go back up
$Voyager Therapeutics (VYGR.US)$ Press Release: Voyager Enters Into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Dow Jones· 2 mins ago
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager to receive upfront consideration of $15 million and is eligible to receive up to $305 million in potential associated milestone payments and royalties
Dow Jones· 2 mins ago
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager to receive upfront consideration of $15 million and is eligible to receive up to $305 million in potential associated milestone payments and royalties
2
$Voyager Therapeutics (VYGR.US)$
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager Therapeutics (Nasdaq: VYGR) has announced a new license agreement with Novartis AG (NYSE: NVS) for a novel capsid from Voyager's TRACER™ capsid discovery platform. The capsid will be used in a gene therapy program targeting an undisclosed rare neurologic disease. This agreement expands Voyager's partnered portfolio of TRACER-enabl...
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager Therapeutics (Nasdaq: VYGR) has announced a new license agreement with Novartis AG (NYSE: NVS) for a novel capsid from Voyager's TRACER™ capsid discovery platform. The capsid will be used in a gene therapy program targeting an undisclosed rare neurologic disease. This agreement expands Voyager's partnered portfolio of TRACER-enabl...
1
$Voyager Therapeutics (VYGR.US)$
Looks like 6 holds the big buy but we shall see. Don't expect it to get much lower.
Looks like 6 holds the big buy but we shall see. Don't expect it to get much lower.
1
$Voyager Therapeutics (VYGR.US)$ Man, I've been holding this for awhile (since late Q1 this year) and it just can't ever seem to get that boost and then that second boost that I was really expecting to come by the end of summer. I guess there's still time and I'm only in @ $7.15 or so, so it could definitely be worse. I'm still expecting this to take off at some point.
$Voyager Therapeutics (VYGR.US)$ Finally some movement on this one I bought in at just under $8 a few months ago and have just been holding while this has seemly remained stagnant. Hopefully today's movement is a nice sign of what is to come 😁.
4
1
$Voyager Therapeutics (VYGR.US)$ Benzinga· 2 mins ago
Voyager Therapeutics Says First Participants Dosed In Single Ascending Dose Trial of VY-TAU01 For Treatment Of Alzheimer's Disease
Voyager Therapeutics Says First Participants Dosed In Single Ascending Dose Trial of VY-TAU01 For Treatment Of Alzheimer's Disease
No comment yet
Space Dust : since mid September.. now in December, patience may be about to pay off.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")